Harrow, Inc. (HROW)
53.54
-0.64
(-1.18%)
USD |
NASDAQ |
Mar 02, 16:00
46.20
-7.34
(-13.71%)
After-Hours: 20:00
Harrow Research and Development Expense (Annual) : 12.95M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Corcept Therapeutics, Inc. | 254.91M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Xeris Biopharma Holdings, Inc. | 25.56M |
| Stoke Therapeutics, Inc. | 86.96M |
| Vir Biotechnology, Inc. | 432.80M |